25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

ELAB (Elevai Labs, Inc. Common Stock) Stock Analysis
Buy, Hold or Sell?

Let's analyze Elevai Labs, Inc. Common Stock together

I guess you are interested in Elevai Labs, Inc. Common Stock. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Elevai Labs, Inc. Common Stock’s Financial Insights
  • 📈 Technical Analysis (TA) – Elevai Labs, Inc. Common Stock’s Price Targets

I'm going to help you getting a better view of Elevai Labs, Inc. Common Stock. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Elevai Labs, Inc. Common Stock

I send you an email if I find something interesting about Elevai Labs, Inc. Common Stock.

1. Quick Overview

1.1. Quick analysis of Elevai Labs, Inc. Common Stock (30 sec.)










1.2. What can you expect buying and holding a share of Elevai Labs, Inc. Common Stock? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$6.58
Expected worth in 1 year
$11.24
How sure are you?
53.8%

+ What do you gain per year?

Total Gains per Share
$4.66
Return On Investment
235.4%

For what price can you sell your share?

Current Price per Share
$1.98
Expected price per share
$1.81 - $3.12
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Elevai Labs, Inc. Common Stock (5 min.)




Live pricePrice per Share (EOD)
$1.98
Intrinsic Value Per Share
$-67.56 - $-80.13
Total Value Per Share
$-60.98 - $-73.55

2.2. Growth of Elevai Labs, Inc. Common Stock (5 min.)




Is Elevai Labs, Inc. Common Stock growing?

Current yearPrevious yearGrowGrow %
How rich?$9m$2.1m$5.9m72.9%

How much money is Elevai Labs, Inc. Common Stock making?

Current yearPrevious yearGrowGrow %
Making money-$1.4m-$1.1m-$213.9k-15.3%
Net Profit Margin-307.3%-191.9%--

How much money comes from the company's main activities?

2.3. Financial Health of Elevai Labs, Inc. Common Stock (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Elevai Labs, Inc. Common Stock?

Welcome investor! Elevai Labs, Inc. Common Stock's management wants to use your money to grow the business. In return you get a share of Elevai Labs, Inc. Common Stock.

First you should know what it really means to hold a share of Elevai Labs, Inc. Common Stock. And how you can make/lose money.

Speculation

The Price per Share of Elevai Labs, Inc. Common Stock is $1.98. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Elevai Labs, Inc. Common Stock.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Elevai Labs, Inc. Common Stock, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $6.58. Based on the TTM, the Book Value Change Per Share is $1.17 per quarter. Based on the YOY, the Book Value Change Per Share is $0.48 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Elevai Labs, Inc. Common Stock.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.41-20.7%-1.02-51.5%-0.80-40.6%-0.66-33.3%-0.61-30.8%-0.61-30.8%
Usd Book Value Change Per Share0.6733.8%1.1758.8%0.4824.1%0.5427.4%0.5125.6%0.5125.6%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.6733.8%1.1758.8%0.4824.1%0.5427.4%0.5125.6%0.5125.6%
Usd Price Per Share2.16-2.29-0.78-1.02-0.94-0.94-
Price to Earnings Ratio-1.32--0.68--0.21--0.30--0.28--0.28-
Price-to-Total Gains Ratio3.23-1.48-1.71-1.58-1.58-1.58-
Price to Book Ratio0.33-0.40-0.34-0.25-0.23-0.23-
Price-to-Total Gains Ratio3.23-1.48-1.71-1.58-1.58-1.58-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.98
Number of shares505
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share1.170.51
Usd Total Gains Per Share1.170.51
Gains per Quarter (505 shares)588.35255.58
Gains per Year (505 shares)2,353.391,022.33
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1023532343010221012
2047074696020452034
3070607049030673056
4094149402040894078
501176711755051125100
601412014108061346122
701647416461071567144
801882718814081798166
902118021167092019188
100235342352001022310210

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.013.00.00.0%0.013.00.00.0%0.013.00.00.0%
Book Value Change Per Share3.01.00.075.0%6.05.01.050.0%7.05.01.053.8%7.05.01.053.8%7.05.01.053.8%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.013.00.0%0.00.013.00.0%0.00.013.00.0%
Total Gains per Share3.01.00.075.0%6.05.01.050.0%7.05.01.053.8%7.05.01.053.8%7.05.01.053.8%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Elevai Labs, Inc. Common Stock compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.6691.165-43%0.476+41%0.543+23%0.506+32%0.506+32%
Book Value Per Share--6.5795.888+12%1.610+309%2.521+161%2.333+182%2.333+182%
Current Ratio--22.3819.643+132%2.047+993%4.477+400%4.329+417%4.329+417%
Debt To Asset Ratio--0.0350.154-77%0.565-94%0.467-93%0.462-92%0.462-92%
Debt To Equity Ratio--0.0360.197-82%0.495-93%4.496-99%4.202-99%4.202-99%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--2644530.6005716061.685-54%1031694.739+156%3708475.851-29%3708475.851-29%3708475.851-29%
Eps---0.409-1.019+149%-0.803+96%-0.659+61%-0.610+49%-0.610+49%
Free Cash Flow Per Share---0.983-0.987+0%-1.074+9%-0.726-26%-0.670-32%-0.670-32%
Free Cash Flow To Equity Per Share--0.0841.043-92%-0.081+197%0.317-74%0.293-71%0.293-71%
Gross Profit Margin--1.0001.140-12%1.257-20%1.167-14%1.154-13%1.154-13%
Intrinsic Value_10Y_max---80.129----------
Intrinsic Value_10Y_min---67.562----------
Intrinsic Value_1Y_max---3.652----------
Intrinsic Value_1Y_min---3.584----------
Intrinsic Value_3Y_max---14.308----------
Intrinsic Value_3Y_min---13.592----------
Intrinsic Value_5Y_max---28.987----------
Intrinsic Value_5Y_min---26.618----------
Market Cap2723252.400-9%2970831.6003150654.435-6%1067019.804+178%1405891.413+111%1297745.920+129%1297745.920+129%
Net Profit Margin----3.0730%-1.9190%-3.1190%-2.9680%-2.9680%
Operating Margin----3.0090%-1.5460%-2.7810%-2.6510%-2.6510%
Operating Ratio---3.076-100%2.396-100%3.423-100%3.320-100%3.320-100%
Pb Ratio0.301-9%0.3280.400-18%0.336-2%0.245+34%0.226+45%0.226+45%
Pe Ratio-1.211+8%-1.321-0.684-48%-0.214-84%-0.299-77%-0.276-79%-0.276-79%
Price Per Share1.980-9%2.1602.291-6%0.776+178%1.022+111%0.944+129%0.944+129%
Price To Free Cash Flow Ratio-0.503+8%-0.549-0.535-3%-0.150-73%-0.228-58%-0.211-62%-0.211-62%
Price To Total Gains Ratio2.958-9%3.2271.480+118%1.711+89%1.579+104%1.579+104%1.579+104%
Quick Ratio--1.9153.938-51%0.943+103%2.026-5%2.022-5%2.022-5%
Return On Assets---0.060-0.147+146%-0.332+453%-0.323+439%-0.319+431%-0.319+431%
Return On Equity---0.062-0.181+192%-0.350+463%-3.185+5026%-2.974+4686%-2.974+4686%
Total Gains Per Share--0.6691.165-43%0.476+41%0.543+23%0.506+32%0.506+32%
Usd Book Value--9049175.0008098118.250+12%2197290.750+312%3631569.333+149%3439241.692+163%3439241.692+163%
Usd Book Value Change Per Share--0.6691.165-43%0.476+41%0.543+23%0.506+32%0.506+32%
Usd Book Value Per Share--6.5795.888+12%1.610+309%2.521+161%2.333+182%2.333+182%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--2644530.6005716061.685-54%1031694.739+156%3708475.851-29%3708475.851-29%3708475.851-29%
Usd Eps---0.409-1.019+149%-0.803+96%-0.659+61%-0.610+49%-0.610+49%
Usd Free Cash Flow---1352298.000-1357984.250+0%-1532196.500+13%-1195942.500-12%-1106253.538-18%-1106253.538-18%
Usd Free Cash Flow Per Share---0.983-0.987+0%-1.074+9%-0.726-26%-0.670-32%-0.670-32%
Usd Free Cash Flow To Equity Per Share--0.0841.043-92%-0.081+197%0.317-74%0.293-71%0.293-71%
Usd Market Cap2723252.400-9%2970831.6003150654.435-6%1067019.804+178%1405891.413+111%1297745.920+129%1297745.920+129%
Usd Price Per Share1.980-9%2.1602.291-6%0.776+178%1.022+111%0.944+129%0.944+129%
Usd Profit---562355.000-1401587.750+149%-1187676.000+111%-1155779.250+106%-1105264.308+97%-1105264.308+97%
Usd Revenue----266927.7500%618334.250-100%202999.667-100%220624.462-100%220624.462-100%
Usd Total Gains Per Share--0.6691.165-43%0.476+41%0.543+23%0.506+32%0.506+32%
 EOD+2 -6MRQTTM+20 -13YOY+31 -33Y+22 -125Y+22 -1210Y+22 -12

3.3 Fundamental Score

Let's check the fundamental score of Elevai Labs, Inc. Common Stock based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.211
Price to Book Ratio (EOD)Between0-10.301
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.915
Current Ratio (MRQ)Greater than122.381
Debt to Asset Ratio (MRQ)Less than10.035
Debt to Equity Ratio (MRQ)Less than10.036
Return on Equity (MRQ)Greater than0.15-0.062
Return on Assets (MRQ)Greater than0.05-0.060
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of Elevai Labs, Inc. Common Stock based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.461
Ma 20Greater thanMa 502.040
Ma 50Greater thanMa 1002.159
Ma 100Greater thanMa 2002.496
OpenGreater thanClose1.990
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Elevai Labs, Inc. Common Stock

PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of cutting-edge aesthetic medicines and therapeutic products. The company's lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity's pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. It is also involved in the medical scientific research and development activities, as well as operates investment firms. The company was formerly known as Elevai Labs, Inc. and changed its name to PMGC Holdings Inc. in December 2024. PMGC Holdings Inc. was incorporated in 2020 and is based in Newport Beach, California.

Fundamental data was last updated by Penke on 2025-08-16 15:25:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Elevai Labs, Inc. Common Stock earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Elevai Labs, Inc. Common Stock to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Elevai Labs, Inc. Common Stock:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-307.3%+307.3%
TTM-307.3%YOY-191.9%-115.4%
TTM-307.3%5Y-296.8%-10.5%
5Y-296.8%10Y-296.8%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--95.1%+95.1%
TTM-307.3%-142.2%-165.1%
YOY-191.9%-199.4%+7.5%
3Y-311.9%-257.3%-54.6%
5Y-296.8%-343.4%+46.6%
10Y-296.8%-503.2%+206.4%
4.3.1.2. Return on Assets

Shows how efficient Elevai Labs, Inc. Common Stock is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Elevai Labs, Inc. Common Stock to the Biotechnology industry mean.
  • -6.0% Return on Assets means that Elevai Labs, Inc. Common Stock generated $-0.06 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Elevai Labs, Inc. Common Stock:

  • The MRQ is -6.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -14.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-6.0%TTM-14.7%+8.8%
TTM-14.7%YOY-33.2%+18.4%
TTM-14.7%5Y-31.9%+17.1%
5Y-31.9%10Y-31.9%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-6.0%-11.6%+5.6%
TTM-14.7%-11.4%-3.3%
YOY-33.2%-11.3%-21.9%
3Y-32.3%-11.6%-20.7%
5Y-31.9%-11.8%-20.1%
10Y-31.9%-13.6%-18.3%
4.3.1.3. Return on Equity

Shows how efficient Elevai Labs, Inc. Common Stock is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Elevai Labs, Inc. Common Stock to the Biotechnology industry mean.
  • -6.2% Return on Equity means Elevai Labs, Inc. Common Stock generated $-0.06 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Elevai Labs, Inc. Common Stock:

  • The MRQ is -6.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -18.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-6.2%TTM-18.1%+11.9%
TTM-18.1%YOY-35.0%+16.8%
TTM-18.1%5Y-297.4%+279.3%
5Y-297.4%10Y-297.4%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-6.2%-13.3%+7.1%
TTM-18.1%-14.5%-3.6%
YOY-35.0%-14.5%-20.5%
3Y-318.5%-16.5%-302.0%
5Y-297.4%-17.1%-280.3%
10Y-297.4%-19.2%-278.2%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Elevai Labs, Inc. Common Stock.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Elevai Labs, Inc. Common Stock is operating .

  • Measures how much profit Elevai Labs, Inc. Common Stock makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Elevai Labs, Inc. Common Stock to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Elevai Labs, Inc. Common Stock:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-300.9%+300.9%
TTM-300.9%YOY-154.6%-146.3%
TTM-300.9%5Y-265.1%-35.9%
5Y-265.1%10Y-265.1%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--193.6%+193.6%
TTM-300.9%-234.1%-66.8%
YOY-154.6%-212.3%+57.7%
3Y-278.1%-240.5%-37.6%
5Y-265.1%-348.6%+83.5%
10Y-265.1%-488.3%+223.2%
4.3.2.2. Operating Ratio

Measures how efficient Elevai Labs, Inc. Common Stock is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Elevai Labs, Inc. Common Stock:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM3.076-3.076
TTM3.076YOY2.396+0.680
TTM3.0765Y3.320-0.244
5Y3.32010Y3.3200.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.026-2.026
TTM3.0762.666+0.410
YOY2.3963.011-0.615
3Y3.4233.512-0.089
5Y3.3204.642-1.322
10Y3.3206.651-3.331
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Elevai Labs, Inc. Common Stock.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Elevai Labs, Inc. Common Stock is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 22.38 means the company has $22.38 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Elevai Labs, Inc. Common Stock:

  • The MRQ is 22.381. The company is very able to pay all its short-term debts. +2
  • The TTM is 9.643. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ22.381TTM9.643+12.738
TTM9.643YOY2.047+7.596
TTM9.6435Y4.329+5.314
5Y4.32910Y4.3290.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ22.3813.543+18.838
TTM9.6433.775+5.868
YOY2.0474.140-2.093
3Y4.4774.680-0.203
5Y4.3295.742-1.413
10Y4.3296.175-1.846
4.4.3.2. Quick Ratio

Measures if Elevai Labs, Inc. Common Stock is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Elevai Labs, Inc. Common Stock to the Biotechnology industry mean.
  • A Quick Ratio of 1.91 means the company can pay off $1.91 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Elevai Labs, Inc. Common Stock:

  • The MRQ is 1.915. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.938. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.915TTM3.938-2.023
TTM3.938YOY0.943+2.995
TTM3.9385Y2.022+1.916
5Y2.02210Y2.0220.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9153.128-1.213
TTM3.9383.433+0.505
YOY0.9433.928-2.985
3Y2.0264.516-2.490
5Y2.0225.876-3.854
10Y2.0226.523-4.501
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Elevai Labs, Inc. Common Stock.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Elevai Labs, Inc. Common Stock assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Elevai Labs, Inc. Common Stock to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.03 means that Elevai Labs, Inc. Common Stock assets are financed with 3.5% credit (debt) and the remaining percentage (100% - 3.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Elevai Labs, Inc. Common Stock:

  • The MRQ is 0.035. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.154. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.035TTM0.154-0.119
TTM0.154YOY0.565-0.410
TTM0.1545Y0.462-0.308
5Y0.46210Y0.4620.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0350.342-0.307
TTM0.1540.356-0.202
YOY0.5650.332+0.233
3Y0.4670.340+0.127
5Y0.4620.350+0.112
10Y0.4620.378+0.084
4.5.4.2. Debt to Equity Ratio

Measures if Elevai Labs, Inc. Common Stock is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Elevai Labs, Inc. Common Stock to the Biotechnology industry mean.
  • A Debt to Equity ratio of 3.6% means that company has $0.04 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Elevai Labs, Inc. Common Stock:

  • The MRQ is 0.036. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.197. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.036TTM0.197-0.161
TTM0.197YOY0.495-0.298
TTM0.1975Y4.202-4.004
5Y4.20210Y4.2020.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0360.390-0.354
TTM0.1970.440-0.243
YOY0.4950.419+0.076
3Y4.4960.455+4.041
5Y4.2020.464+3.738
10Y4.2020.511+3.691
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Elevai Labs, Inc. Common Stock generates.

  • Above 15 is considered overpriced but always compare Elevai Labs, Inc. Common Stock to the Biotechnology industry mean.
  • A PE ratio of -1.32 means the investor is paying $-1.32 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Elevai Labs, Inc. Common Stock:

  • The EOD is -1.211. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.321. Based on the earnings, the company is expensive. -2
  • The TTM is -0.684. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.211MRQ-1.321+0.110
MRQ-1.321TTM-0.684-0.637
TTM-0.684YOY-0.214-0.470
TTM-0.6845Y-0.276-0.408
5Y-0.27610Y-0.2760.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.211-2.649+1.438
MRQ-1.321-2.092+0.771
TTM-0.684-2.761+2.077
YOY-0.214-3.911+3.697
3Y-0.299-3.894+3.595
5Y-0.276-6.363+6.087
10Y-0.276-6.876+6.600
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Elevai Labs, Inc. Common Stock:

  • The EOD is -0.503. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.549. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.535. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.503MRQ-0.549+0.046
MRQ-0.549TTM-0.535-0.014
TTM-0.535YOY-0.150-0.385
TTM-0.5355Y-0.211-0.324
5Y-0.21110Y-0.2110.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.503-3.863+3.360
MRQ-0.549-2.839+2.290
TTM-0.535-3.941+3.406
YOY-0.150-4.426+4.276
3Y-0.228-5.256+5.028
5Y-0.211-8.609+8.398
10Y-0.211-9.357+9.146
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Elevai Labs, Inc. Common Stock is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.33 means the investor is paying $0.33 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Elevai Labs, Inc. Common Stock:

  • The EOD is 0.301. Based on the equity, the company is cheap. +2
  • The MRQ is 0.328. Based on the equity, the company is cheap. +2
  • The TTM is 0.400. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.301MRQ0.328-0.027
MRQ0.328TTM0.400-0.071
TTM0.400YOY0.336+0.064
TTM0.4005Y0.226+0.173
5Y0.22610Y0.2260.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.3012.398-2.097
MRQ0.3281.907-1.579
TTM0.4002.210-1.810
YOY0.3362.517-2.181
3Y0.2452.530-2.285
5Y0.2263.717-3.491
10Y0.2264.400-4.174
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2024-06-302024-09-302024-12-312025-03-312025-06-30
Total Other Income Expense Net -4-578-582524-58-321-379777398



6.2. Latest Balance Sheet

Balance Sheet of 2025-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets9,375
Total Liabilities326
Total Stockholder Equity9,049
 As reported
Total Liabilities 326
Total Stockholder Equity+ 9,049
Total Assets = 9,375

Assets

Total Assets9,375
Total Current Assets7,303
Long-term Assets2,073
Total Current Assets
Cash And Cash Equivalents 5,683
Short-term Investments 625
Total Current Assets  (as reported)7,303
Total Current Assets  (calculated)6,307
+/- 995
Long-term Assets
Property Plant Equipment 3
Intangible Assets 2,073
Long-term Assets  (as reported)2,073
Long-term Assets  (calculated)2,075
+/- 3

Liabilities & Shareholders' Equity

Total Current Liabilities326
Long-term Liabilities0
Total Stockholder Equity9,049
Total Current Liabilities
Accounts payable 272
Total Current Liabilities  (as reported)326
Total Current Liabilities  (calculated)272
+/- 55
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Total Stockholder Equity (as reported)9,049
Total Stockholder Equity (calculated)0
+/- 9,049
Other
Capital Stock1
Common Stock Shares Outstanding 1,375
Net Invested Capital 9,049
Net Working Capital 6,977



6.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-30
> Total Assets 
1,892
1,892
1,892
1,744
1,744
1,583
5,190
4,227
5,080
11,205
8,993
8,889
9,375
9,3758,8898,99311,2055,0804,2275,1901,5831,7441,7441,8921,8921,892
   > Total Current Assets 
1,501
1,501
1,501
1,451
1,451
1,277
4,919
3,141
2,031
8,228
6,051
6,816
7,303
7,3036,8166,0518,2282,0313,1414,9191,2771,4511,4511,5011,5011,501
       Cash And Cash Equivalents 
1,155
1,155
1,155
601
601
477
3,327
944
100
6,426
3,984
5,364
5,683
5,6835,3643,9846,4261009443,3274776016011,1551,1551,155
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
557
625
62555700000000000
       Net Receivables 
13
13
13
34
34
8
36
54
29
28
5
52
0
05252829543683434131313
       Inventory 
244
244
244
478
478
499
496
945
979
986
0
0
0
000986979945496499478478244244244
       Other Current Assets 
90
90
153
337
337
44
1,061
1,198
923
788
2,061
842
0
08422,0617889231,1981,061443373371539090
   > Long-term Assets 
391
391
391
293
293
543
270
1,086
3,049
2,978
2,942
2,073
2,073
2,0732,0732,9422,9783,0491,086270543293293391391391
       Property Plant Equipment 
330
330
330
283
283
296
260
232
193
154
1
3
3
331154193232260296283283330330330
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
139
0
0
001390000000000
       Intangible Assets 
0
0
0
0
0
0
844
844
2,845
2,824
2,802
2,073
2,073
2,0732,0732,8022,8242,845844844000000
       Long-term Assets Other 
50
50
50
11
11
237
11
11
11
0
0
0
0
00001111112371111505050
> Total Liabilities 
761
761
761
1,677
1,677
1,747
1,363
1,740
2,441
2,650
2,334
760
326
3267602,3342,6502,4411,7401,3631,7471,6771,677761761761
   > Total Current Liabilities 
588
588
588
1,563
1,563
1,644
1,297
1,222
1,935
2,130
1,799
760
326
3267601,7992,1301,9351,2221,2971,6441,5631,563588588588
       Short-term Debt 
111
111
111
115
115
141
145
149
140
103
0
0
0
000103140149145141115115111111111
       Accounts payable 
222
222
211
538
538
573
596
395
1,141
1,079
481
384
272
2723844811,0791,141395596573538538211222222
       Other Current Liabilities 
255
255
257
825
825
875
520
1,226
630
909
1,318
376
0
03761,3189096301,226520875825825257255255
   > Long-term Liabilities 
173
173
173
114
114
103
65
518
505
520
534
0
0
0053452050551865103114114173173173
> Total Stockholder Equity
1,131
1,131
1,131
67
67
-164
3,827
2,486
2,640
8,555
6,660
8,129
9,049
9,0498,1296,6608,5552,6402,4863,827-16467671,1311,1311,131
   Common Stock
1
1
1
1
1
1
2
2
2
5
0
0
0
0005222111111
   Retained Earnings -15,440-14,878-13,270-11,335-9,834-8,421-7,024-5,866-5,083-5,083-2,722-2,722-2,722
   Accumulated Other Comprehensive Income 
0
0
0
0
0
1
0
1
1
0
0
-1
0
0-100110100000
   Capital Surplus 0000000000000
   Treasury Stock0000000000000
   Other Stockholders Equity 
3,852
3,852
3,852
5,148
5,148
5,700
10,849
10,904
12,470
19,885
19,929
23,007
0
023,00719,92919,88512,47010,90410,8495,7005,1485,1483,8523,8523,852



6.4. Balance Sheets

Currency in USD. All numbers in thousands.




6.5. Cash Flows

Currency in USD. All numbers in thousands.




6.6. Income Statements

Currency in USD. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue2,467
Cost of Revenue-670
Gross Profit1,7971,797
 
Operating Income (+$)
Gross Profit1,797
Operating Expense-3,664
Operating Income-1,867-1,866
 
Operating Expense (+$)
Research Development105
Selling General Administrative563
Selling And Marketing Expenses293
Operating Expense3,664960
 
Net Interest Income (+$)
Interest Income13
Interest Expense-735
Other Finance Cost-0
Net Interest Income-722
 
Pretax Income (+$)
Operating Income-1,867
Net Interest Income-722
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-4,017283
EBIT - interestExpense = -4,017
-6,246
-5,511
Interest Expense735
Earnings Before Interest and Taxes (EBIT)-3,282-3,282
Earnings Before Interest and Taxes (EBITDA)-3,198
 
After tax Income (+$)
Income Before Tax-4,017
Tax Provision-0
Net Income From Continuing Ops-4,017-4,017
Net Income-6,246
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses4,334
Total Other Income/Expenses Net-2,150722
 

Technical Analysis of Elevai Labs, Inc. Common Stock
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Elevai Labs, Inc. Common Stock. The general trend of Elevai Labs, Inc. Common Stock is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Elevai Labs, Inc. Common Stock's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Elevai Labs, Inc. Common Stock Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Elevai Labs, Inc. Common Stock.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 2.6972 < 2.89 < 3.12.

The bearish price targets are: 1.81.

Know someone who trades $ELAB? Share this with them.👇

Elevai Labs, Inc. Common Stock Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Elevai Labs, Inc. Common Stock. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Elevai Labs, Inc. Common Stock Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Elevai Labs, Inc. Common Stock. The current macd is -0.08469639.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Elevai Labs, Inc. Common Stock price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Elevai Labs, Inc. Common Stock. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Elevai Labs, Inc. Common Stock price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Elevai Labs, Inc. Common Stock Daily Moving Average Convergence/Divergence (MACD) ChartElevai Labs, Inc. Common Stock Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Elevai Labs, Inc. Common Stock. The current adx is 17.30.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Elevai Labs, Inc. Common Stock shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Elevai Labs, Inc. Common Stock Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Elevai Labs, Inc. Common Stock. The current sar is 2.34230513.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Elevai Labs, Inc. Common Stock Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Elevai Labs, Inc. Common Stock. The current rsi is 44.46. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -3/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
Elevai Labs, Inc. Common Stock Daily Relative Strength Index (RSI) ChartElevai Labs, Inc. Common Stock Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Elevai Labs, Inc. Common Stock. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 2/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Elevai Labs, Inc. Common Stock price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Elevai Labs, Inc. Common Stock Daily Stochastic Oscillator ChartElevai Labs, Inc. Common Stock Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Elevai Labs, Inc. Common Stock. The current cci is -41.85225018.

Elevai Labs, Inc. Common Stock Daily Commodity Channel Index (CCI) ChartElevai Labs, Inc. Common Stock Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Elevai Labs, Inc. Common Stock. The current cmo is -6.22003707.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Elevai Labs, Inc. Common Stock Daily Chande Momentum Oscillator (CMO) ChartElevai Labs, Inc. Common Stock Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Elevai Labs, Inc. Common Stock. The current willr is -65.30612245.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Elevai Labs, Inc. Common Stock is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Elevai Labs, Inc. Common Stock Daily Williams %R ChartElevai Labs, Inc. Common Stock Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Elevai Labs, Inc. Common Stock.

Elevai Labs, Inc. Common Stock Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Elevai Labs, Inc. Common Stock. The current atr is 0.14234061.

Elevai Labs, Inc. Common Stock Daily Average True Range (ATR) ChartElevai Labs, Inc. Common Stock Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Elevai Labs, Inc. Common Stock. The current obv is 26,189,599.

Elevai Labs, Inc. Common Stock Daily On-Balance Volume (OBV) ChartElevai Labs, Inc. Common Stock Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Elevai Labs, Inc. Common Stock. The current mfi is 55.24.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Elevai Labs, Inc. Common Stock Daily Money Flow Index (MFI) ChartElevai Labs, Inc. Common Stock Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Elevai Labs, Inc. Common Stock.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-03-31WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-04-09RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-04-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-14RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-15STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-04-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-04-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-30STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-01RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-05-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-14MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-15STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-16STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-20CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-21STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-23STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-05-30STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-04STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-05STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-12STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-18STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-20STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-24STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-30STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-01CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-07-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-08STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-07-09CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-07-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-11CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-15STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-18STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-22STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-23WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-07-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-07-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-07-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-08-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-04STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-05STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-08-06STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-08MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-08-11STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-08-14STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-08-15STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-08-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.

6.3. Candlestick Patterns

Elevai Labs, Inc. Common Stock Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Elevai Labs, Inc. Common Stock based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.461
Ma 20Greater thanMa 502.040
Ma 50Greater thanMa 1002.159
Ma 100Greater thanMa 2002.496
OpenGreater thanClose1.990
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Elevai Labs, Inc. Common Stock with someone you think should read this too:
  • Are you bullish or bearish on Elevai Labs, Inc. Common Stock? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Elevai Labs, Inc. Common Stock? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Elevai Labs, Inc. Common Stock

I send you an email if I find something interesting about Elevai Labs, Inc. Common Stock.


Comments

How you think about this?

Leave a comment

Stay informed about Elevai Labs, Inc. Common Stock.

Receive notifications about Elevai Labs, Inc. Common Stock in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.